Physician
Dickson Medical Associates PC
Dickson Medical Associates PC was paid $11.31M by Medicaid between Jan 2018 and Dec 2024, across 208 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoDICKSON MEDICAL ASSOCIATES PC
DICKSON, TN 37055
DICKSON, TN 37055
33aNPI1568464873assigned 06/01/2005
33bProvider typeFamily Medicine Physician
28Total paid$11.31M
24GClaims642,460
24DCodes billed208
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Tennessee
Rank by total paid#11 of 754
Median peer was paid$34K
This provider vs. median335×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 71,307 | $1.33M | |
| 2019 | 66,284 | $1.25M | |
| 2020 | 66,213 | $1.16M | |
| 2021 | 74,679 | $1.43M | |
| 2022 | 112,153 | $1.93M | |
| 2023 | 142,829 | $2.39M | |
| 2024incomplete | 108,995 | $1.83M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 93,085 | 80,350 | $3.07M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 60,724 | 50,621 | $2.26M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.2% | 8,092 | 7,413 | $594K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.8% | 8,417 | 7,361 | $541K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.6% | 7,966 | 6,787 | $403K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 7,384 | 6,601 | $321K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.7% | 2,292 | 2,153 | $305K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.5% | 5,248 | 4,693 | $282K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.1% | 3,330 | 2,910 | $241K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.0% | 12,276 | 10,946 | $226K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.9% | 8,800 | 7,848 | $218K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.8% | 15,144 | 13,394 | $200K |
196 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 18,561 | $198K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 2,596 | $185K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.4% | 682 | $156K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 13,294 | $129K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 7,811 | $106K |
| 95886 | <1% | 892 | $104K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 6,384 | $102K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,232 | $97K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 7,353 | $94K |
| 99381 | <1% | 1,110 | $80K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,437 | $77K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 600 | $71K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,732 | $69K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,278 | $60K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,226 | $57K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 652 | $52K |
| 36415 | Collection of venous blood by venipuncture | <1% | 35,582 | $39K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,272 | $38K |
| 99177 | <1% | 6,314 | $38K | |
| 80061 | Lipid panel | <1% | 11,182 | $37K |
| 80050 | General health panel | <1% | 1,571 | $34K |
| 93000 | <1% | 4,414 | $34K | |
| 95911 | <1% | 265 | $33K | |
| 20610 | <1% | 1,277 | $30K | |
| 90473 | <1% | 2,293 | $29K | |
| 95117 | <1% | 2,452 | $27K | |
| 3008F | <1% | 31,161 | $26K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 272 | $21K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 133 | $20K |
| 99385 | <1% | 218 | $20K | |
| 95811 | <1% | 90 | $19K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 281 | $18K |
| 95819 | <1% | 184 | $18K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 254 | $18K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,247 | $18K |
| 96161 | <1% | 1,475 | $18K | |
| 80053 | Comprehensive metabolic panel | <1% | 9,321 | $18K |
| 72110 | <1% | 769 | $16K | |
| 97161 | <1% | 383 | $16K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,287 | $15K |
| 99173 | <1% | 2,567 | $14K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 32 | $14K |
| 99307 | <1% | 2,078 | $13K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,600 | $13K |
| 95913 | <1% | 70 | $12K | |
| 99383 | <1% | 154 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,603 | $12K |
| 90674 | <1% | 1,463 | $12K | |
| 96127 | <1% | 2,799 | $11K | |
| 92551 | <1% | 1,483 | $11K | |
| 92552 | <1% | 703 | $10K | |
| 72100 | <1% | 776 | $10K | |
| 81001 | <1% | 6,422 | $10K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 873 | $10K |
| 0240U | <1% | 69 | $10K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 44 | $9K |
| 88304 | <1% | 406 | $8K | |
| 95024 | <1% | 102 | $8K | |
| 99382 | <1% | 97 | $8K | |
| 95806 | <1% | 84 | $7K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 81 | $7K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 281 | $6K |
| 83735 | <1% | 1,921 | $6K | |
| 81003 | <1% | 4,306 | $6K | |
| 87631 | <1% | 92 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,441 | $5K |
| 90670 | <1% | 5,201 | $5K | |
| 73110 | <1% | 270 | $5K | |
| 84481 | <1% | 818 | $5K | |
| 82570 | <1% | 2,968 | $4K | |
| 36416 | <1% | 3,084 | $4K | |
| 17110 | <1% | 114 | $4K | |
| 83655 | <1% | 345 | $4K | |
| 85018 | <1% | 1,802 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 116 | $4K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 113 | $4K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 14 | $4K |
| 93356 | <1% | 242 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,249 | $3K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 63 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 171 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 32 | $3K |
| 82043 | <1% | 3,010 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 78 | $3K |
| 93015 | <1% | 106 | $3K | |
| 90686 | <1% | 3,777 | $3K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 194 | $3K |
| 96160 | <1% | 217 | $3K | |
| 84439 | <1% | 1,090 | $3K | |
| 3074F | <1% | 32,743 | $3K | |
| 64405 | <1% | 74 | $3K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 16 | $2K |
| 3078F | <1% | 29,057 | $2K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 16 | $2K |
| 90677 | <1% | 1,064 | $2K | |
| 73560 | <1% | 232 | $2K | |
| 3079F | <1% | 9,899 | $2K | |
| 94010 | <1% | 90 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,307 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 100 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 28 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 205 | $2K |
| 82607 | <1% | 565 | $2K | |
| 88302 | <1% | 130 | $2K | |
| 88312 | <1% | 90 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 29 | $2K |
| 85652 | <1% | 773 | $2K | |
| 90681 | <1% | 2,244 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 286 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 286 | $1K |
| 85060 | <1% | 210 | $1K | |
| 90723 | <1% | 4,579 | $1K | |
| 0011A | <1% | 41 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 60 | $1K |
| 87807 | <1% | 117 | $1K | |
| 99305 | <1% | 50 | $1K | |
| 0012A | <1% | 32 | $1K | |
| 86706 | <1% | 202 | $1K | |
| 73610 | <1% | 70 | $1K | |
| 86803 | <1% | 142 | $987.14 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 33 | $914.66 |
| 90651 | <1% | 101 | $887.33 | |
| 99223 | Prolong inpt eval add15 m | <1% | 16 | $882.87 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 25 | $859.98 |
| 73030 | <1% | 61 | $836.26 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 483 | $799.97 |
| 82040 | <1% | 599 | $733.47 | |
| 3044F | <1% | 2,173 | $730.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 17 | $695.67 |
| 3077F | <1% | 3,822 | $690.00 | |
| 73130 | <1% | 41 | $685.65 | |
| 86705 | <1% | 105 | $629.70 | |
| 82746 | <1% | 191 | $600.31 | |
| 84134 | <1% | 176 | $595.86 | |
| 90710 | <1% | 653 | $589.25 | |
| 99490 | Ccm add 20min | <1% | 75 | $580.77 |
| 3075F | <1% | 3,003 | $570.00 | |
| 73630 | <1% | 53 | $563.04 | |
| 97014 | <1% | 84 | $541.66 | |
| 73564 | <1% | 27 | $514.50 | |
| 99441 | <1% | 36 | $511.62 | |
| 11100 | <1% | 12 | $494.06 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 14 | $493.25 |
| 99406 | <1% | 78 | $485.72 | |
| 85610 | <1% | 422 | $454.88 | |
| 90633 | <1% | 2,464 | $425.24 | |
| 99442 | <1% | 13 | $399.19 | |
| 90648 | <1% | 6,354 | $397.11 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 126 | $397.10 |
| 85027 | <1% | 235 | $395.96 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 180 | $370.58 |
| 80305 | <1% | 69 | $370.44 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 678 | $332.88 |
| 86140 | <1% | 247 | $304.01 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 17 | $298.29 |
| 87640 | <1% | 94 | $267.74 | |
| 87641 | <1% | 94 | $267.74 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 53 | $265.20 |
| 94060 | <1% | 15 | $245.92 | |
| 73502 | <1% | 14 | $245.04 | |
| 94729 | <1% | 13 | $235.35 | |
| 3080F | <1% | 1,154 | $220.00 | |
| 93228 | <1% | 16 | $215.31 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 12 | $196.38 |
| 90661 | <1% | 241 | $194.05 | |
| 93922 | <1% | 15 | $167.95 | |
| 99407 | <1% | 23 | $148.98 | |
| 90672 | <1% | 28 | $122.36 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 25 | $119.38 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 36 | $116.79 |
| 83540 | <1% | 160 | $84.41 | |
| 3061F | <1% | 1,322 | $54.00 | |
| 80076 | <1% | 33 | $51.90 | |
| G0008 | Administration of influenza virus vaccine | <1% | 312 | $29.77 |
| 82565 | <1% | 14 | $28.29 | |
| 84520 | <1% | 14 | $21.66 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 62 | $11.21 |
| 1159F | <1% | 9,091 | $10.00 | |
| 1125F | 0% | 1,124 | $0.00 | |
| 90716 | 0% | 609 | $0.00 | |
| 3048F | 0% | 2,352 | $0.00 | |
| 99000 | 0% | 1,711 | $0.00 | |
| 3049F | 0% | 156 | $0.00 | |
| 4050F | 0% | 1,206 | $0.00 | |
| 1170F | 0% | 84 | $0.00 | |
| 91301 | 0% | 74 | $0.00 | |
| 1126F | 0% | 20 | $0.00 | |
| 90696 | 0% | 29 | $0.00 | |
| 3060F | 0% | 16 | $0.00 | |
| 1160F | 0% | 6,607 | $0.00 | |
| 90734 | 0% | 41 | $0.00 | |
| 90707 | 0% | 642 | $0.00 | |
| 3050F | 0% | 119 | $0.00 | |
| 90700 | 0% | 369 | $0.00 | |
| 1158F | 0% | 21 | $0.00 | |
| 90685 | 0% | 103 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTRONG, CHRISTIE (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Dickson Medical Associates, PC | Waverly, TN | $943.10 |
| Dickson Medical Associates, PC | Waverly, TN | $829.22 |
| Dickson Medical Associates, PC | Dickson, TN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.